Open-Label, Fixed-Sequence, Crossover Study To Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2011
At a glance
- Drugs Lamivudine/abacavir; Lersivirine
- Indications HIV infections
- Focus Pharmacokinetics
- 03 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2010 Planned end date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 08 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.